High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure
JAMA · 11.03.2025 · 333 (10) · 875
DOI: 10.1001/jama.2024.26244 ↗Kurz gefasst
Äquivalenzstudie in der Zeitschrift JAMA, erschienen am 11.03.2025. Verfasst von RENOVATE Investigators and the BRICNet Authors und 54 weiteren Autor:innen. Beteiligte Einrichtung: Hcor Research Institute, São Paulo, Brazil. Hauptthemen laut MEDLINE: Noninvasive Ventilation, Oxygen Inhalation Therapy, Respiratory Insufficiency. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance High-flow nasal oxygen (HFNO) and noninvasive ventilation (NIV) are commonly used respiratory support therapies for patients with acute respiratory failure (ARF).
Objective
To assess whether HFNO is noninferior to NIV on the rates of endotracheal intubation or death at 7 days in 5 patient groups with ARF. Design, Setting, and Participants This noninferiority, randomized clinical trial enrolled hospitalized adults (aged ≥18 years; classified as 5 patient groups with ARF: nonimmunocompromised with hypoxemia, immunocompromised with hypoxemia, chronic obstructive pulmonary disease [COPD] exacerbation with respiratory acidosis, acute cardiogenic pulmonary edema [ACPE], or hypoxemic COVID-19, which was added as a separate group on June 26, 2023) at 33 hospitals in Brazil between November 2019 and November 2023 (final follow-up: April 26, 2024).
Interventions
High-flow nasal oxygen (n = 883) or NIV (n = 883). Main Outcomes and Measures The primary outcome was endotracheal intubation or death within 7 days assessed using a bayesian hierarchical model with dynamic borrowing across patient groups. Noninferiority was defined by a posterior probability of 0.992 or greater for an odds ratio (OR) less than 1.55.
Results
Among 1800 patients, 1766 completed the study (mean age, 64 [SD, 17] years; 707 [40%] were women). The primary outcome of endotracheal intubation or death at 7 days occurred in 39% (344/883) in the HFNO group vs 38% (336/883) in the NIV group. In the immunocompromised with hypoxemia patient group, the primary outcome occurred in 57.1% (16/28) in the HFNO group vs 36.4% (8/22) in the NIV group; enrollment was stopped for futility (final OR, 1.07; 95% credible interval [CrI], 0.81-1.39; noninferiority posterior probability [NPP], 0.989). In the nonimmunocompromised with hypoxemia group, the primary outcome occurred in 32.5% (81/249) in the HFNO group vs 33.1% (78/236) in the NIV group (OR, 1.02 [95% CrI, 0.81-1.26]; NPP, 0.999). In the ACPE group, the primary outcome occurred in 10.3% (14/136) in the HFNO group vs 21.3% (29/136) in the NIV group (OR, 0.97 [95% CrI, 0.73-1.23]; NPP, 0.997). In the hypoxemic COVID-19 group, the primary outcome occurred in 51.3% (223/435) in the HFNO group vs 47.0% (210/447) in the NIV group (OR, 1.13 [95% CrI, 0.94-1.38]; NPP, 0.997). In the COPD exacerbation with respiratory acidosis group, the primary outcome occurred in 28.6% (10/35) in the HFNO group vs 26.2% (11/42) in the NIV group (OR, 1.05 [95% CrI, 0.79-1.36]; NPP, 0.992). However, a post hoc analysis without dynamic borrowing across the 5 ARF patient groups revealed some qualitatively different results in patients with COPD, immunocompromised patients, and patients with ACPE. The incidence of serious adverse events was similar (9.4% of patients in HFNO group vs 9.9% in NIV group). Conclusions and Relevance Compared with NIV, HFNO met prespecified criteria for noninferiority for the primary outcome of endotracheal intubation or death within 7 days in 4 of the 5 patient groups with ARF. However, the small sample sizes in some patient groups and the sensitivity of the findings to the choice of analysis model suggests the need for further study in patients with COPD, immunocompromised patients, and patients with ACPE. Trial Registration ClinicalTrials.gov Identifier: NCT03643939
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hcor Research Institute, São Paulo, Brazil.
- Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
- Hospital Nereu Ramos, Florianópolis, Brazil.
- Universidade Federal de Santa Catarina, Florianópolis, Brazil.
- MAGIC Evidence Ecosystem Foundation, Oslo, Norway.
- Divisão de Pneumologia, Instituto do Coracao, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Zitieren
APA
RENOVATE Investigators and the BRICNet Authors, Maia, I. S., Kawano-Dourado, L., Tramujas, L., de Oliveira, N. E., Souza, R. N., Signorini, D. F., Pincelli, M. P., Zandonai, C. L., Blasius, R. T., Freires, F., Ferreira, V. M., Romano, M. L. P., Miura, M. C., de Censo, C. M., Caser, E. B., Silva, B., Santos Bonomo, D. C., Arraes, J. A., …, & Biasi Cavalcanti, A. (2025). High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure. JAMA, 333(10), 875. https://doi.org/10.1001/jama.2024.26244
Vancouver
RENOVATE Investigators and the BRICNet Authors, Maia IS, Kawano-Dourado L, Tramujas L, de Oliveira NE, Souza RN, et al. High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure. JAMA. 2025;333(10):875. doi:10.1001/jama.2024.26244
BibTeX
@article{RENOVATEInvestigatorsandtheBRICNetAuthors2025,
author = {RENOVATE Investigators and the BRICNet Authors, RENOVATE Investigators and the BRICNet Authors and Maia, Israel S and Kawano-Dourado, Letícia and Tramujas, Lucas and de Oliveira, Neymar Elias and Souza, Rafael Naoki and Signorini, Dhaisi Faustino and Pincelli, Mariangela Pimentel and Zandonai, Cássio Luis and Blasius, Regiane Tamires and Freires, Fabrício and Ferreira, Vanessa Marques and Romano, Marcelo Luz Pereira and Miura, Mieko Claudia and de Censo, Caroline Maschio and Caser, Eliana Bernadete and Silva, Betania and Santos Bonomo, Daniela Correia and Arraes, Jussara Alencar and de Alencar Filho, Meton Soares and Álvares Horta, Jacques Gabriel and Oliveira, Déborah Campos and Boschi, Emerson and Costa, Rafael Lessa and Westphal, Glauco Adrieno and Ramos, Juliano and Lacerda, Fábio Holanda and Filho, Conrado Roberto Hoffmann and Pinheiro, Bruno Valle and de Andrade Neumamm, Leonardo Bugarin and Guimarães Júnior, Mário Roberto Rezende and de Souza, Davi Tamamaru and Ferreira, Juliana Carvalho and Ohe, Louis Nakayama and Schettini, Daniel Almeida and Thompson, Marlus Muri and de Oliveira, Maria Cristina França and Veiga, Viviane Cordeiro and Negrelli, Karina L and Santos, Renato H N and Damiani, Lucas and Gurgel, Rodrigo M and Gomes, Samara P C and Lima, Lucas M and Miranda, Tamiris A and Laranjeira, Ligia N and de Barros E Silva, Pedro Gabriel Melo and Machado, Flávia R and Fitzgerald, Mark and Bosse, Anna and Marion, Joe and Carvalho, Carlos Roberto Ribeiro and Brochard, Laurent and Lewis, Roger J and Biasi Cavalcanti, Alexandre},
title = {High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure},
journal = {JAMA},
year = {2025},
volume = {333},
number = {10},
pages = {875},
doi = {10.1001/jama.2024.26244}
}
EUVIMED